| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JPS.2600810802 |
| P698 | PubMed publication ID | 1403714 |
| P2093 | author name string | A Sette | |
| H Grey | |||
| F Gaeta | |||
| M F Powell | |||
| S Colón | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 731-735 | |
| P577 | publication date | 1992-08-01 | |
| P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
| P1476 | title | Peptide stability in drug development: a comparison of peptide reactivity in different biological media | |
| P478 | volume | 81 |
| Q43744520 | 'Troy-bodies': antibodies as vector proteins for T cell epitopes |
| Q40963061 | A structure-based approach to designing non-natural peptides that can activate anti-melanoma cytotoxic T cells. |
| Q36740783 | Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo. |
| Q45722933 | Anti-human immunodeficiency virus-gag CD8+ memory T cells generated in vitro from Listeria-immunized mice |
| Q52205193 | Assessment of complex peptide degradation pathways via structured multicompartmental modeling approaches: the metabolism of dynorphin A1-13 and related fragments in human plasma. |
| Q34730713 | Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvant |
| Q41807091 | Cathelicidin-trypsin inhibitor loop conjugate represents a promising antibiotic candidate with protease stability |
| Q37228833 | Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens. |
| Q42778271 | Current challenges in peptide-based drug discovery |
| Q40649809 | Degradation of the immunogenic peptide gp100(280-288) by the monocyte-like U937 cell line. |
| Q92255648 | Design and Biological Evaluation of Colchicine-CD44-Targeted Peptide Conjugate in an In Vitro Model of Crystal Induced Inflammation |
| Q34040946 | Design and development of a peptide-based adiponectin receptor agonist for cancer treatment |
| Q52537084 | Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide. |
| Q34048086 | Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII. |
| Q41013632 | Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays |
| Q93928169 | Enzymatic degradation of leuprolide in rat intestinal mucosal homogenates |
| Q33827338 | Fungal homoserine kinase (thr1Delta) mutants are attenuated in virulence and die rapidly upon threonine starvation and serum incubation |
| Q45053347 | Identification of stabilized dynorphin derivatives for suppressing tolerance in morphine-dependent rats. |
| Q30834739 | In situ stimulation of a T helper cell hybridoma with a cellulose-bound peptide antigen |
| Q28543699 | In vitro metabolic stability of exendin-4: pharmacokinetics and identification of cleavage products |
| Q43723268 | In vitro stability of alpha-helical peptide nucleic acids (alphaPNAs). |
| Q37786707 | In vivo biodistribution and efficacy of peptide mediated delivery |
| Q42126995 | Insect peptides with improved protease-resistance protect mice against bacterial infection |
| Q42997052 | Link peptide cartilage growth factor is degraded by membrane proteinases |
| Q36596283 | Mesencephalic astrocyte-derived neurotrophic factor (MANF) secretion and cell surface binding are modulated by KDEL receptors. |
| Q40268569 | Nuclear medicine imaging and therapy of neuroendocrine tumours |
| Q37200462 | Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia |
| Q72589601 | Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum |
| Q33698159 | Pharmacokinetics of LJP 993, a tetrameric conjugate of domain 1 of beta2-glycoprotein I for antiphospholipid syndrome |
| Q34308017 | Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections |
| Q73925309 | Quantitative analysis of exogenous peptides in plasma using immobilized enzyme cleavage and gas chromatography-mass spectrometry with negative ion chemical ionization |
| Q52568841 | Range of activity and metabolic stability of synthetic antibacterial glycopeptides from insects. |
| Q42049840 | Specific VEGF sequestering to biomaterials: influence of serum stability. |
| Q71648133 | Stability and in vitro metabolism of the mitogenic neuropeptide antagonists [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P and [Arg6, D-Trp7,9, MePhe8-substance P (6–11) characterized by high-performance liquid chromatography |
| Q38264736 | Strategic approaches to optimizing peptide ADME properties |
Search more.